Back to Journals » Drug Design, Development and Therapy » Volume 5

Original Research

Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial

       
Total article views   HTML views PDF downloads Totals
20,120 Dovepress* 16,547+ 2,453 19,000
PubMed Central* 3,573 786 4,359
Totals 20,120 3,239 23,359
*Since 11 July 2011
+Since July 2016

View citations on PubMed and Google Scholar